Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001
-
Shares outstanding
-
53,041,500
-
Total 13F shares
-
33,695,414
-
Share change
-
-1,578,558
-
Total reported value
-
$276,632,230
-
Put/Call ratio
-
107%
-
Price per share
-
$8.21
-
Number of holders
-
126
-
Value change
-
-$28,175,573
-
Number of buys
-
64
-
Number of sells
-
71
Institutional Holders of Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) as of Q2 2024
As of 30 Jun 2024 Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) had 126 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 33,695,414 shares of stock of the company.
Largest 10 holders included CAS Investment Partners, LLC, BlackRock Inc., VANGUARD GROUP INC, MORGAN STANLEY, 683 Capital Management, LLC, KPS Global Asset Management UK Ltd, WORLDLY PARTNERS MANAGEMENT, LLC, BRIGHTLIGHT CAPITAL MANAGEMENT LP, GEODE CAPITAL MANAGEMENT, LLC, and STATE STREET CORP.
This table shows 123 institutional shareholders of the security as of 30 Jun 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.